kabutan

Cyfuse Biomedical Opens Higher as AMED Backs Severe Periodontitis Treatment Project

Mon Apr 13, 2026 9:06 am JST Catalyst

Cyfuse Biomedical K.K. <4892> opened heavily bid. After the market close on the 10th, Cyfuse announced that its joint project with Hiroshima University, "Development of Innovative Periodontal Tissue Regeneration Therapy Using Three-Dimensional Transplant Tissue Created with Bio-3D Printer," was selected for the Japan Agency for Medical Research and Development (AMED)'s "FY2026 Research Project for Practical Application of Regenerative Medicine." Following this selection, the project aimed at establishing a treatment for severe periodontitis will advance from basic research to clinical development, fueling buying interest on expectations of accelerated commercialization.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles